AMG232 |
AMG232 : Inhibitor of MDM2-p53 interaction
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MDM2 |
|
|
Inhibitor
10-100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
AMG232 showed minimal activity in CYP3A4-inhibition assay and PXR-induction assay.
Potency Cellular
In Vitro
MDM2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm401753e
In Vivo Validations
Rat, Athymic, nude mice
Dose: 0.5 mg/kg (rat)
Route of delivery:
Intravenous, Subcutaneous
Plasma half life:
2.4 h
Systemic clearance:
0.66 L/h/kg
Organ of interest (O):
SJSA-1 xenograft
Target engagement assay:
AMG232 dose-dependently increased p21 RNA in xenografts.
DOI Reference: 10.1021/jm401753e
Chemical Information
| Molecular Formula | C28H35Cl2NO5S |
| SMILEs | CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1 |
| InChI | InChI=1S/C28H35Cl2NO5S/c1-17(2)24(16-37(35,36)18(3)4)31-26(19-9-11-21(29)12-10-19)23(20-7-6-8-22(30)13-20)14-28(5,27(31)34)15-25(32)33/h6-13,17-18,23-24,26H,14-16H2,1-5H3,(H,32,33)/t23-,24-,26-,28-/m1/s1 |
| Molecular weight | 567.16 Da |
| AlogP | 6.3794 |
| HBond acceptors | 6 |
| HBond donors | 1 |
| Atoms | 72 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.